Clinical Tumor Anemia Registry (TAR)

iOMEDICO

Status: Completed

Conditions: Anemia

Study type: Observational

Funder types: Industry; Other

Identifiers

NCT01795690

iOM TAR

Details and patient eligibility

About

The purpose of this registry is to record information of routine treatment of anemia in cancer patients in Germany. An overview of the current treatment of anemia in German outpatient centers and hospitals will be provided. Primary outcome parameters, e.g. improvement in hemoglobin levels and changes in QoL, as well as patient characteristics of different treatments will be analyzed.

Enrollment: 1,018 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Histologically confirmed malignant disease
• Hemoglobin level < 11 g/dl (female) or < 12 g/dl (male)
• Start of antianemic therapy no more than 7 days prior to informed consent
• Performance status 0 - 3 (Karnofsky-Index >= 40%)
• Minimum age: 18 years
• Informed written consent

Exclusion criteria

• Hypersensitivity against antianemic therapies
• Myelodysplastic Syndrome
• Experimental antianemic therapy